In CRC cell lines, CDKN2A is methylated in up to 75% of cases [24, 25], and CDKN2A hypermethylation has been proposed to be part of a cell line-specific DNA methylation pattern [24]. This evidence concerns the gene CDKN2A and colorectal carcinoma.